Misoprostol
The Social Life of a Life-saving Drug in Global Maternal Health
Bibliographic Data
| ID | 5337639 |
|---|---|
| Authors | M E Macdonald (0000-0002-8432-5544, York University, corresponding author) |
| Year | 2021 |
| Volume | 46 |
| Issue | 2 |
| Pages | 376-401 |
| Publication date | 2021-03-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Science Technology & Human Values (JOURNAL) |
| Journal identifiers | ISSN: 0162-2439 • E-ISSN: 1552-8251 |
| Publisher | SAGE Publications Inc (PUBLISHER) |
| DOI | 10.1177/0162243920916781 |
| OpenAlex | W3023751098 |
| Language | EN |
| Citations received | 14 |
| References cited | 42 |
This paper is about a drug called misoprostol and its controversial clinical and social lives. Although originally developed as a prevention for gastric ulcers, in the 1980s, it developed an off-label reputation as an abortifacient. The drug's association with clandestine abortion has profoundly shaped its social life as a marginal and suspect character in the realm of global maternal and reproductive health where it has the potential to prevent two major causes of maternal death--postpartum hemorrhage and unsafe abortion. The social life of misoprostol has also been shaped by the question of authoritative practice, that is, the question of who can deliver medicine. Both issues are about the specters of misuse of misoprostol: off-label, illegal, immoral, or by unlicensed providers. In this paper, I focus ethnographically on two women's health nongovernmental organizations that have been conducting clinical testing and advocacy for the use of misoprostol for reproductive indications in global maternal health settings. Drawing on the notions of pharmaceutical activism and protocol feminism, I describe and analyze how the tools of evidence and authoritative practice have been reassembled in new networks of expertise toward the social justice goals of life, access, and dignity for women
Abortion · Dignity · Environmental health · Family planning · Misoprostol · Political science · Population · Pregnancy · Public relations · Reproductive health · Reproductive rights · Unsafe abortion · Global Maternal and Child Health · Law · Maternal and Perinatal Health Interventions · Medicine · Prenatal Substance Exposure Effects
The Innovation Imperative in Global Health
Transgressing biomedical and legal boundaries
The Duogynon controversy and ignorance production in post-thalidomide West Germany
A Stalled Revolution? Misoprostol and the Pharmaceuticalization of Reproductive Health in Francophone Africa
Revolutionary pills? Feminist abortion, pharmaceuticalization, and reproductive governance
Lively and Unstable Implosions
A pill to control the uterus
Toward Transnational Feminist Methodologies in Global Health
Legal geographies of medication abortion in the USA
De "droga do século XXI" a "abortivo vendido ilegalmente
Misoprostol on trial
The Chemical Geographies of Misoprostol
What Counts as Global Health
Savoirs et ignorances disputés des médicaments 'détournés' en gynécologie-obstétrique
Shaping technology/building society
Fluid Drugs
Childbirth and Authoritative Knowledge
Life in Crisis
The System of Professions
Global causes of maternal death
Maternal Mortality-a Neglected Tragedy
Global, regional, and national levels of maternal mortality, 1990–2015
Unsafe Motherhood
The return of the Traditional Birth Attendant
A Pill in the Lifeworld of Women in Burkina Faso
New hope
Humanitarian neophilia
Seizing the Means of Reproduction
The Construction of Lay Expertise
Right tool," wrong "job
Health consumption as work
Too far to walk
Community mobilization to reduce postpartum hemorrhage in home births in northern Nigeria
Medications as Social Phenomena
The biomedicalisation of illegal abortion
Pharmaceuticalization
The Activist State
Managing Motherhood, Managing Risk
Anthropology in Public Health
The Charm of Medicines
Biomedical Practice and Anthropological Theory
For a Sociology of Expertise
Normalizing Off-Label Experiments and the Pharmaceuticalization of Homebirths in Pakistan
| Unique citing works | 14 |
|---|---|
| Citations per year | 2,8 |
| Citation span | 2021 - 2026 (6) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 12 |